Special Issue "Microencapsulation Technology Applied to Pharmaceutics 2014"


A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: 29 September 2014

Special Issue Editors

Guest Editor
Prof. Dr. Denis Poncelet
Oniris, rue de la géraudière, BP 82225, 44322 Nantes, France
E-Mail: denis.poncelet@oniris-nantes.fr
Phone: +33 2 51 78 54 25
Interests: bioencapsulation; solid dispersion

Guest Editor
Prof. Dr. Thierry Vandamme
Laboratory for the Conception and Application of Bioactive Molecules, UMR 7199 CNRS, Faculty of Pharmacy, University of Strasbourg, France
E-Mail: thierry.vandamme@pharma.u-strasbg.fr
Interests: the design and the formulation of drugs by using microencapsulation technologies; in vitro / in vivo drug release and mathematical modeling; controlled release of drugs from different raw materials allowing sustained release or targeting; application for different administration routes

Special Issue Information

Dear Colleagues,

Microencapsulation is one of the techniques able to overcome the drug stability problem, and moreover, the possibility of formulating encapsulated drug delivery systems with controlled release rates. On these bases, microencapsulated dosage forms represent effective new therapeutic platforms. The active molecules are protected as long as they reach their specific action site. Most of the applied techniques of micro-encapsulation are based on modifications of the three basic methods: spray-drying, phase separation (coacervation), and solvent extraction/evaporation.

This special issue will cover the different interests of microencapsulation as a means to control or modify the release of drug substances from drug delivery systems. Since clinical efficacies have been reported to be improved by the encapsulation of pharmaceuticals, the bioavailability of drugs, control drug release kinetics, minimizing drug side effects, and taste masking of the bitter taste of drug substances will be discussed.

Prof. Dr. Denis Poncelet
Prof. Dr. Thierry Vandamme
Guest Editors


Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.


  • microencapsulation
  • encapsulation
  • encapsulation efficiency
  • coacervation
  • entrapment
  • lipid formulation
  • water-in-oil emulsion
  • spray-congealing
  • emulsion solvent evaporation
  • membrane emulsification
  • size controlled emulsion
  • drug; targeting
  • microspheres
  • microparticles
  • microcapsules
  • coating
  • emulsion
  • polymeric drug delivery systems
  • spray-drying
  • taste masking
  • aerosol
  • electrospray
  • self microemulsifying

Related Special Issue

Published Papers (5 papers)

by ,  and
Pharmaceutics 2013, 5(4), 609-620; doi:10.3390/pharmaceutics5040609
Received: 26 September 2013; in revised form: 30 October 2013 / Accepted: 12 November 2013 / Published: 21 November 2013
Show/Hide Abstract | PDF Full-text (469 KB) | HTML Full-text | XML Full-text

by , ,  and
Pharmaceutics 2014, 6(1), 80-96; doi:10.3390/pharmaceutics6010080
Received: 24 January 2014; in revised form: 5 March 2014 / Accepted: 6 March 2014 / Published: 14 March 2014
Show/Hide Abstract | PDF Full-text (2069 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , ,  and
Pharmaceutics 2014, 6(1), 185-194; doi:10.3390/pharmaceutics6010185
Received: 17 January 2014; in revised form: 27 February 2014 / Accepted: 13 March 2014 / Published: 24 March 2014
Show/Hide Abstract | PDF Full-text (1856 KB) | HTML Full-text | XML Full-text
abstract graphic

by ,  and
Pharmaceutics 2014, 6(2), 281-297; doi:10.3390/pharmaceutics6020281
Received: 21 January 2014; in revised form: 9 May 2014 / Accepted: 20 May 2014 / Published: 13 June 2014
Show/Hide Abstract | PDF Full-text (1220 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , , , , , , ,  and
Pharmaceutics 2014, 6(3), 447-466; doi:10.3390/pharmaceutics6030447
Received: 24 March 2014; in revised form: 2 July 2014 / Accepted: 30 July 2014 / Published: 11 August 2014
Show/Hide Abstract | PDF Full-text (1590 KB) | HTML Full-text | XML Full-text
abstract graphic

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Last update: 7 August 2014

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert